Viewing Study NCT02319460


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-02-28 @ 12:03 AM
Study NCT ID: NCT02319460
Status: COMPLETED
Last Update Posted: 2021-05-26
First Post: 2014-12-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
Sponsor: CSL Behring
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hemorrhage View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vitamin K Reversal Antagonist Therapy of Acute Major Bleeding View
None Warfarin Reversal View